MYND Life Sciences Inc. — Capital/Financing Update 2021

May 26, 2021

MYND LIFE SCIENCES INC.

Notice Declaring Intention to be Qualified under National Instrument 44-101 Short Form Prospectus Distributions (“NI 44-101”)

TO : British Columbia Securities Commission, as principal regulator

MYND Life Sciences Inc. (the “ Issuer ”) intends to be qualified to file a short form prospectus under NI 44-101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer's intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer.

DATED this 26[th] day of May, 2021.

MYND LIFE SCIENCES INC.

(s) “Lyle Oberg” Per: Lyle Oberg Chief Executive Officer